Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 64,817 full-time employees. The company went IPO on 2009-09-18. The firm's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
The most recent EPS for Koninklijke Philips N.V. is $0.23, beating expectations of $0.2.
How did Koninklijke Philips N.V. PHG's revenue perform in the last quarter?
Koninklijke Philips N.V. revenue for the last quarter is $0.23
What is the revenue estimate for Koninklijke Philips N.V.?
According to 8 of Wall street analyst, the revenue estimate of Koninklijke Philips N.V. range from $4.67B to $4.27B
What's the earning quality score for Koninklijke Philips N.V.?
Koninklijke Philips N.V. has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Koninklijke Philips N.V. report earnings?
Koninklijke Philips N.V. next earnings report is expected in 2026-08-04
What are Koninklijke Philips N.V.'s expected earnings?
Koninklijke Philips N.V. expected earnings is $3.95B, according to wall-street analysts.
Did Koninklijke Philips N.V. beat earnings expectations?
Koninklijke Philips N.V. recent earnings of $3.9B does not beat expectations.